+44 115 7870500
DevelRx Logo
HomeTeam
Services
Research & Candidate SelectionDrug DevelopmentRegistrationMarketing
News & EventsPartnersContact
DevelRx Logo
HomeTeam
Services
Research & Candidate SelectionDrug DevelopmentRegistrationMarketing
News & EventsPartnersContact

News

We invite you to attend our presentation ‘Psychedelics and CNS Drugs with Novel Mechanisms. Non-clinical Abuse Evaluations to Meet the Challenge’ Continuing Education Course, Virtual SPS Meeting, October 2021

Read More

The Next Trip - Developing the Second Generation of Psychedelics and their Analogs for Targeted Medical Use. Watch our podcast on 21st September 2021

Read More

Congratulations to Cara Therapeutics and Vifor Pharma on the FDA approval of Korsuva

Read More

What are the prospects for new drugs for binge-eating disorder?

Read More

DevelRx announces collaboration with Scitegrity

Read More

Does every CNS drug-candidate require a program of GLP non-clinical abuse potential testing?

Read More

Join us at the 83rd Annual Scientific Virtual Meeting of the CPDD,  21st- 24th June, 2021

Read More

How can non-clinical research inform the clinical development and prescribing of psychedelic drugs?

Read More

Congratulations to our colleague, Dr Jo Palandri, on her recent publication in the Journal of Psychopharmacology!

Read More

How do we Adapt to Continue Making Accurate, Experimental-Based Predictions of Drug Abuse Risks? DevelRx takes great pleasure to announce that we will be co-hosting a workshop at the 83rd Annual Scientific Virtual Meeting of the College on Problems of Drug Dependence (CPDD) conference, June 19th - 23rd 2021:

Read More

DevelRx was very pleased to assist Always Pure Organics with the preparation of their three dossiers that were submitted to the FSA last month for Cannabidiol (CBD)-based Novel Foods; one for their Swiss Isolate, one for their Colombian Isolate and one for their Colombian Distillate.

Read More

BPS, LASA & Psychiatry Consortium joint workshop: Exploring the Status of Preclinical Models of Psychiatric Disorders - Their Validity and Scope for Successful Translation - 25th February 2021

Read More

DevelRx continues its medical education support for psychiatrists and other healthcare providers treating attention deficit hyperactivity disorder.

Read More

Professor David Heal will be co-presenting two posters at the American College of Neuropsychopharmacology (ACNP) 59th Annual Meeting - Virtual Conference to be held from 6th to 9th December, 2020.

Read More

David Heal will give a presentation at the American College of Toxicology Virtual Meeting (November 12th to 19th 2020) as part of the Continuing Education Course—CE07 entitled “Understanding the Assessment of Abuse Potential: Industry and Regulatory Perspective”

Read More

Professor David Heal, Dr Sharon Smith and Dr Reem Elbekai will be co-presenting two posters on Centanafadine at the American College of Toxicology (ACT) Virtual Meeting (November 12th to 19th 2020).

Read More

DevelRx is delighted to announce that the University of Bath and DevelRx have agreed to co-sponsor a PhD project entitled “Mu and kappa opioid receptors in addictive behaviour”.

Read More

DevelRx Logo

Biocity,

Pennyfoot Street,

Nottingham,

Nottinghamshire,

NG1 1GF

Legal

Cookie PolicyPrivacy PolicyTerms & Conditions
inform@develrx.com

Follow us on LinkedIn

Registered in England and Wales

Company number: 12028847